Amniotic membrane can be a valid source for wound healing.

Area of Science:

• Regenerative Medicine
• Wound Healing Biology
• Biomaterials Science

Background:

• Chronic leg ulcers present a significant clinical challenge due to impaired healing.
• Amniotic membrane (AM) possesses properties that may support tissue regeneration and suppress fibrosis.
• The potential of AM scaffolds in modulating wound healing requires further investigation.

Purpose of the Study:

• To evaluate the efficacy of amniotic membrane (AM) scaffolds in promoting chronic wound healing.
• To determine if AM promotes tissue reconstruction rather than scar tissue formation.
• To assess the impact of AM on ulcer healing rate, size, and pain levels.

Main Methods:

• Amniotic membrane (AM) was prepared and applied to chronic leg ulcers in a study group (n=14).
• A control group (n=11) received conventional wound dressings.
• Outcomes including ulcer size, healing rate, granulation tissue presence, and pain were assessed over 60 days.

Main Results:

• The AM group showed complete ulcer healing in 14-60 days with a mean healing rate of 0.896 cm²/day.
• Healthy granulation tissue was observed in 92.9% of AM-treated ulcers, compared to 18.2% in the control group.
• Significant pain reduction was reported in 78.6% of patients treated with AM.

Conclusions:

• Amniotic membrane (AM) grafts demonstrate significant value in accelerating chronic wound healing.
• AM promotes healthy tissue regeneration and pain reduction in chronic leg ulcers.
• Further research is warranted to confirm these promising findings and explore AM's therapeutic potential.